Hostname: page-component-78c5997874-ndw9j Total loading time: 0 Render date: 2024-11-03T03:06:21.476Z Has data issue: false hasContentIssue false

Oral Sernyl in Obsessive States

Published online by Cambridge University Press:  08 February 2018

Brian M. Davies*
Affiliation:
Bethlem Royal and Maudsley Hospitals

Extract

Sernyl, 1 aryl-cyclo-hexylamine, is a synthetic drug first used by the anaesthetists because, when given intravenously, it produces analgesia. However, the occurrence of psychological disturbances post-operatively led to the investigation of this drug by psychiatrists. It was found that Sernyl produces many interesting psychological disturbances, some of which resemble the primary symptoms of schizophrenia (Davies and Beech, 1960). In a previous paper (Davies, 1960) Sernyl was given intravenously to five patients with long-standing psychoneurotic illnesses. It proved to be an effective abreactive agent and produced some interesting results in three of the patients who had obsessional symptoms. Sernyl, in the doses used, is not an hallucinogen, though it produces other effects similar to lysergic acid diethylamide, which has been used extensively as a therapeutic agent, particularly in obsessional states (Sandison et al., 1954). The preliminary report suggested that Sernyl might have some practical advantages over LSD—in particular, it produced a less severe disturbance and its effects were over more quickly. Further investigations were clearly indicated and this present paper reports on the use of oral Sernyl in five patients with obsessional illnesses.

Type
Original Articles
Copyright
Copyright © Royal College of Psychiatrists, 1961 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Davies, B. M., J. Ment. Sci., 1960, 106, 1073.CrossRefGoogle Scholar
2. Idem , and Beech, H. R., J. Ment. Sci., 1960, 106, 912.CrossRefGoogle Scholar
3. Kennedy, A., Lancet 1960, 1, 1257.CrossRefGoogle Scholar
4. Sandison, R. A., Spencer, A. M., and Whitelaw, J. D. A., J. Ment. Sci., 1954, 100, 491.CrossRefGoogle Scholar
Submit a response

eLetters

No eLetters have been published for this article.